Pharma R&D Production Research Science 
Drug Discovery World
APRIL 24, 2024
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.
Drug Discovery World
AUGUST 7, 2024
The inequality between near-zero-cost AI-driven drug discovery and skyrocketing costs for clinical trials and regulatory approval will create a bottleneck, stalling promising drugs from reaching patients unless AI is equally applied across the entire R&D lifecycle. Singhal is the company’s president; Wickramasekara its CEO.
Expert insights. Personalized for you.
130 
Let's personalize your content